RecruitingPhase 2NCT02185443

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases

Stereotactic Body Radiation Therapy for the Treatment of Unresectable Liver Metastases in Patients With Colorectal Adenocarcinoma, Carcinoma of the Anal Canal and Gastrointestinal Neuroendocrine Tumors


Sponsor

University of Sao Paulo

Enrollment

43 participants

Start Date

May 1, 2014

Study Type

INTERVENTIONAL

Conditions

Summary

This is a Phase II study to determine the efficacy of SBRT to treat liver metastases in patients with Colorectal Adenocarcinoma, Carcinoma of the Anal Canal and Gastrointestinal Neuroendocrine Tumors that are not amenable to surgery. Patients should have no evidence of extra-hepatic disease or have disease that is planned to be treated with curative intent. Therefore, SBRT is being considered as a potentially curative procedure.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying Stereotactic Body Radiation Therapy (SBRT) — a very precise, high-dose radiation treatment — for people with liver metastases (cancer that has spread to the liver) from colorectal cancer, anal canal cancer, or gastrointestinal neuroendocrine tumors, who cannot be treated with surgery. **You may be eligible if...** - You have 1 to 4 liver metastases, each no larger than 5 cm across - Your liver metastases come from colorectal cancer, anal canal cancer, or gastrointestinal neuroendocrine tumors - Surgery is not suitable for you, or you are considered too frail for surgery - There is no cancer spread outside the liver (or any extrahepatic disease is being treated with curative intent) - Your blood counts and general health are acceptable **You may NOT be eligible if...** - You are receiving chemotherapy at the same time as radiation - You have had prior radiation to the upper abdomen - You are pregnant - You have liver cirrhosis or active hepatitis - You are on blood-thinning medication Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONSBRT

* 60Gy in 3 fractions (20Gy/fraction) over 14 days * 60Gy in 5 fractions (12Gy/fraction) over 18 days if organ at risk constraints cannot be met with fractionation above


Locations(1)

Instituto do Cancer do Estado de São Paulo

São Paulo, São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02185443


Related Trials